AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32382082 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk additional chromosomal abnormalities (ACAs)
Number of subjects: 1510
Study 32382082 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytogenetic monitoring
Number of subjects: 1510
Study 35689489 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids plus 200 mg itacitinib once daily
Number of subjects: 210
Study 35689489 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids plus placebo
Number of subjects: 210
Study 33152609 — intervention group
Group type: EXPERIMENTAL
Intervention: Running technique retraining programme (n = 39)
Number of subjects: 180
Study 33152609 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased step frequency (15%) retraining programme (n = 37)
Number of subjects: 180
Study 33152609 — intervention group
Group type: EXPERIMENTAL
Intervention: Barefoot training (n = 30)
Number of subjects: 180
Study 33152609 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) (n = 43)
Number of subjects: 180
Study 32618695 — intervention group
Group type: EXPERIMENTAL
Intervention: IV albumin
Number of subjects: 1931
Study 32618695 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexisting hypertension
Number of subjects: 1931
Study 32618695 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexisting renal disease
Number of subjects: 1931
Study 32618695 — intervention group
Group type: COMPARATOR
Intervention: CT angiography
Number of subjects: 1931
Study 32618695 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment
Number of subjects: 1931
Study 32618695 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute kidney injury
Number of subjects: 1931
Study 35713042 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons with >3 years of post-fellowship experience (Group 1)
Number of subjects: 134
Study 35713042 — intervention group
Group type: COMPARATOR
Intervention: Surgeons with <3 years of post-fellowship experience (Group 2)
Number of subjects: 134
Study 33492696 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep serratus anterior plane block
Number of subjects: 40
Study 33492696 — intervention group
Group type: COMPARATOR
Intervention: Sham block (placebo injection)
Number of subjects: 40
Study 34403081 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (50 mg daily)
Number of subjects: 18
Study 34403081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 32416964 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in salt taste sensitivity
Number of subjects: 0
Study 32416964 — intervention group
Group type: COMPARATOR
Intervention: No increase in salt taste sensitivity
Number of subjects: 0
Study 35050954 — intervention group
Group type: EXPERIMENTAL
Intervention: Drama therapy for 8 weeks
Number of subjects: 42
Study 35050954 — intervention group
Group type: EXPERIMENTAL
Intervention: Drama therapy for 12 weeks
Number of subjects: 42
Study 33121028 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation problem-based learning (S-PBL) for a week using a childbirth patient simulator (Gaumard® Noelle® S554.100) in small groups.
Number of subjects: 78
Study 33121028 — intervention group
Group type: COMPARATOR
Intervention: Traditional maternity clinical practicum for a week.
Number of subjects: 78
Study 36573450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilofexor (10 to 300 mg fasting or fed, 15 and 50 mg twice-daily fed)
Number of subjects: 120
Study 36573450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilofexor (doses >30 mg)
Number of subjects: 120
Study 36573450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilofexor
Number of subjects: 120
Study 36573450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33763917 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 103
Study 36323052 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy
Number of subjects: 0
Study 36323052 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0
Study 33172506 — intervention group
Group type: EXPERIMENTAL
Intervention: OMNI (animal-derived protein diet; n=9; 1.8 g/kg body mass per day)
Number of subjects: 19
Study 33172506 — intervention group
Group type: EXPERIMENTAL
Intervention: VEG (vegan protein diet; n=10; mycoprotein providing 57% of daily protein intake; 1.8 g/kg body mass per day)
Number of subjects: 19
Study 33172506 — intervention group
Group type: COMPARATOR
Intervention: Comparison of OMNI and VEG
Number of subjects: 19
Study 34773261 — intervention group
Group type: EXPERIMENTAL
Intervention: ligelizumab 240 mg
Number of subjects: 237
Study 32439253 — intervention group
Group type: EXPERIMENTAL
Intervention: TelePR programme (3 weekly training sessions, performance data sent through an app)
Number of subjects: 94
Study 32439253 — intervention group
Group type: EXPERIMENTAL
Intervention: TelePR programme
Number of subjects: 94
Study 32439253 — intervention group
Group type: COMPARATOR
Intervention: Usual care (advised to exercise regularly)
Number of subjects: 94
Study 32439253 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 94
Study 32161055 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial combination therapy with ambrisentan plus tadalafil (COMB)
Number of subjects: 216
Study 32161055 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy of either ambrisentan or tadalafil (MONO)
Number of subjects: 216
Study 36117457 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 24
Study 36117457 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 24
Study 32150048 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SHAM)
Number of subjects: 100
Study 32150048 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT with red laser (660 nm, 0.034 cm, 88 J/cm, 100 mW, 3 J/point)
Number of subjects: 100
Study 32150048 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT with infrared laser (808 nm, 0.034 cm, 88 J/cm, 100 mW, 3 J/point)
Number of subjects: 100
Study 32150048 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT with red and infrared laser alternated between sessions
Number of subjects: 100
Study 32578037 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based interventions (MBIs)
Number of subjects: 138
Study 32578037 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventions (EIs)
Number of subjects: 138
Study 33829844 — intervention group
Group type: EXPERIMENTAL
Intervention: Linking methods by Choi et al. (2014)
Number of subjects: 0
Study 33829844 — intervention group
Group type: EXPERIMENTAL
Intervention: Linking in internal data
Number of subjects: 0
Study 33829844 — intervention group
Group type: EXPERIMENTAL
Intervention: Imputation using bridge study data from external data
Number of subjects: 0
Study 33829844 — intervention group
Group type: EXPERIMENTAL
Intervention: Imputation using bridge study data from internal data
Number of subjects: 0
Study 33829844 — intervention group
Group type: EXPERIMENTAL
Intervention: Imputation methods with patient demographics
Number of subjects: 0
Study 33829844 — intervention group
Group type: COMPARATOR
Intervention: Linking methods
Number of subjects: 0
Study 35257993 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong/Tai Chi
Number of subjects: 20
Study 35257993 — intervention group
Group type: EXPERIMENTAL
Intervention: Latin dance
Number of subjects: 20
Study 35257993 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study 33004682 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloaded sprint training (G0%)
Number of subjects: 28
Study 33004682 — intervention group
Group type: EXPERIMENTAL
Intervention: Resisted sprint training (G40%)
Number of subjects: 28
Study 33004682 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (G0% and G40%)
Number of subjects: 28
Study 34043677 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency image-guided radiotherapy (hfIGRT)
Number of subjects: 4430
Study 34043677 — intervention group
Group type: COMPARATOR
Intervention: No hfIGRT (Control)
Number of subjects: 4430
Study 36123717 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy with patient’s musical preference at 60 dB
Number of subjects: 68
Study 36123717 — intervention group
Group type: COMPARATOR
Intervention: Headphones without any musical transmission (Control)
Number of subjects: 68
Study 33436462 — intervention group
Group type: EXPERIMENTAL
Intervention: Carer Support Needs Assessment Tool for Stroke (CSNAT‐Stroke) intervention
Number of subjects: 21
Study 34866340 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdiscectomy at 6 weeks from onset of symptoms
Number of subjects: 122
Study 34866340 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdiscectomy at 3 months from onset of symptoms
Number of subjects: 122
Study 34866340 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdiscectomy at 6 months from onset of symptoms
Number of subjects: 122
Study 33516014 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried citrus pulp (DCP) at 150 g/kg
Number of subjects: 24
Study 33516014 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape pomace (DGP) at 150 g/kg
Number of subjects: 24
Study 33516014 — intervention group
Group type: COMPARATOR
Intervention: Control diet (CON)
Number of subjects: 24
Study 34106648 — intervention group
Group type: EXPERIMENTAL
Intervention: 45° prone position ventilation (PPV) for 7 days
Number of subjects: 268
Study 34106648 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 268
Study 34106648 — intervention group
Group type: EXPERIMENTAL
Intervention: 45° prone position ventilation (PPV)
Number of subjects: 268
Study 34812127 — intervention group
Group type: EXPERIMENTAL
Intervention: Alive A. muciniphila
Number of subjects: 0
Study 34812127 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasteurized A. muciniphila
Number of subjects: 0
Study 34812127 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33208739 — intervention group
Group type: EXPERIMENTAL
Intervention: Household level
Number of subjects: 1082100
Study 33208739 — intervention group
Group type: EXPERIMENTAL
Intervention: Community level
Number of subjects: 1082100
Study 33208739 — intervention group
Group type: EXPERIMENTAL
Intervention: District level
Number of subjects: 1082100
Study 33208739 — intervention group
Group type: EXPERIMENTAL
Intervention: State level
Number of subjects: 1082100
Study 33208739 — intervention group
Group type: EXPERIMENTAL
Intervention: Economically developed districts
Number of subjects: 1082100
Study 35781191 — intervention group
Group type: COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Number of subjects: 27
Study 33927126 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation for 1 year
Number of subjects: 164
Study 33927126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 34472200 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐mg flunarizine hydrochloride capsules (test)
Number of subjects: 63
Study 34472200 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐mg flunarizine hydrochloride capsules (test) with high-fat meals
Number of subjects: 63
Study 34472200 — intervention group
Group type: COMPARATOR
Intervention: 5‐mg flunarizine hydrochloride capsules (reference)
Number of subjects: 63
Study 32571381 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring visits by local NAPPMED
Number of subjects: 160
Study 32571381 — intervention group
Group type: COMPARATOR
Intervention: Regulatory agencies
Number of subjects: 160
Study 36097005 — intervention group
Group type: EXPERIMENTAL
Intervention: Urate-lowering therapies (ULT) - allopurinol and febuxostat, treated during at least 75% of the study period (PT ≥ 75; n=51)
Number of subjects: 1673
Study 36097005 — intervention group
Group type: EXPERIMENTAL
Intervention: Urate-lowering therapies (ULT) - treated less than 75% of the study period (PT < 75; n=31)
Number of subjects: 1673
Study 36097005 — intervention group
Group type: COMPARATOR
Intervention: Non-treated participants (PNT; n=1591)
Number of subjects: 1673
Study 33743283 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan-enriched diet
Number of subjects: 218
Study 33743283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 32058675 — intervention group
Group type: EXPERIMENTAL
Intervention: Active air purifier
Number of subjects: 90
Study 32058675 — intervention group
Group type: COMPARATOR
Intervention: Inactive air purifier
Number of subjects: 90
Study 36500997 — intervention group
Group type: EXPERIMENTAL
Intervention: Padres program (intervention)
Number of subjects: 94
Study 36500997 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment control group
Number of subjects: 94
Study 32930845 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PCNL) in patients with SCI
Number of subjects: 117
Study 32930845 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients with complete staghorn calculus, GSS=4)
Number of subjects: 117
Study 32084445 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventions targeting leadership, clinicians, and patients, followed by behavioral economics-informed clinician feedback on statin uptake.
Number of subjects: 0
Study 32084445 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral economics-informed clinician feedback on statin uptake.
Number of subjects: 0
Study 32084445 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventions targeting leadership, clinicians, and patients.
Number of subjects: 0
Study 32084445 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of educational interventions and clinician feedback.
Number of subjects: 0
Study 36191982 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 6
Study 36191982 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH)D3
Number of subjects: 6
Study 33583034 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of dexamethasone (12 mg)
Number of subjects: 1000
Study 33583034 — intervention group
Group type: COMPARATOR
Intervention: Lower dose of dexamethasone (6 mg)
Number of subjects: 1000
Study 35899336 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia+lidocaine
Number of subjects: 169
Study 35899336 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia+ibuprofen suppository
Number of subjects: 169
Study 35899336 — intervention group
Group type: COMPARATOR
Intervention: Three-drug combination (general anesthesia + lidocaine + ibuprofen suppository)
Number of subjects: 169
Study 35899336 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 169
Study 32565008 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day methylphenidate
Number of subjects: 180
Study 32565008 — intervention group
Group type: EXPERIMENTAL
Intervention: DCA
Number of subjects: 180
Study 32565008 — intervention group
Group type: EXPERIMENTAL
Intervention: NPI-apathy
Number of subjects: 180
Study 32498871 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised SIMPLISMA algorithm
Number of subjects: 0
Study 32498871 — intervention group
Group type: COMPARATOR
Intervention: Principal Component Analysis (PCA)
Number of subjects: 0
Study 35047059 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study 36137626 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based Radio-Taiso exercise and nutrition programme
Number of subjects: 226
Study 36137626 — intervention group
Group type: COMPARATOR
Intervention: Nutrition programme
Number of subjects: 226
Study 33158705 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart-Class group
Number of subjects: 57
Study 33158705 — intervention group
Group type: COMPARATOR
Intervention: Traditional group
Number of subjects: 57
Study 34535162 — intervention group
Group type: EXPERIMENTAL
Intervention: DISCO App (intervention arm 2 and arm 3)
Number of subjects: 0
Study 34535162 — intervention group
Group type: EXPERIMENTAL
Intervention: DISCO App with intervention booster (intervention arm 3)
Number of subjects: 0
Study 34535162 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control arm 1)
Number of subjects: 0
Study 32487184 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative electron radiotherapy (IOERT) - 21 Gy to the 90% isodose during breast conserving surgery (BCS)
Number of subjects: 202
Study 32487184 — intervention group
Group type: COMPARATOR
Intervention: Standard hypofractionated whole-breast radiotherapy (WBI) - 40.05 Gy, 15 fractions after surgical resection
Number of subjects: 202
Study 32487184 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative electron radiotherapy (IOERT)
Number of subjects: 202
Study 32487184 — intervention group
Group type: COMPARATOR
Intervention: Standard hypofractionated whole-breast radiotherapy (WBI)
Number of subjects: 202
Study 35965423 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT) guided by a hemodynamic monitoring system
Number of subjects: 60
Study 35965423 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid therapy based on mean arterial pressure and diuresis
Number of subjects: 60
Study 34028009 — intervention group
Group type: EXPERIMENTAL
Intervention: Situation awareness model consisting of regional early warning score, skin observation, clinical concern, patients’ and relatives’ concerns, pain, dyspnea, and team risk assessment.
Number of subjects: 21839
Study 34028009 — intervention group
Group type: COMPARATOR
Intervention: Conventional early warning score system (control group).
Number of subjects: 21839
Study 35677096 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine drugs combined with cardiac rehabilitation for 6 months
Number of subjects: 100
Study 35677096 — intervention group
Group type: COMPARATOR
Intervention: Routine drug therapy
Number of subjects: 100
Study 36606020 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 5mg three times a day for the first month and 10mg three times a day for the second month (n=18)
Number of subjects: 30
Study 36606020 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=12)
Number of subjects: 30
Study 36606020 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Buspirone and Placebo)
Number of subjects: 30
Study 35725294 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo + continued MTX
Number of subjects: 398
Study 35725294 — intervention group
Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 398
Study 32163637 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein cholesterol (LDL-C)
Number of subjects: 400
Study 32163637 — intervention group
Group type: COMPARATOR
Intervention: Estimated BMD (eBMD)
Number of subjects: 400
Study 35659704 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg (ipi3)
Number of subjects: 718
Study 35659704 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg (ipi10)
Number of subjects: 718
Study 35659704 — intervention group
Group type: COMPARATOR
Intervention: High-dose IFNα (HDI)
Number of subjects: 718
Study 35659704 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood analysis
Number of subjects: 718
Study 35659704 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor gene expression profiling (GEP)
Number of subjects: 718
Study 33854983 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemented formula with prebiotics and OPO
Number of subjects: 108
Study 33854983 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 108
Study 32875756 — intervention group
Group type: EXPERIMENTAL
Intervention: TightRope group
Number of subjects: 128
Study 32875756 — intervention group
Group type: COMPARATOR
Intervention: Double Endobutton group
Number of subjects: 128
Study 32875756 — intervention group
Group type: COMPARATOR
Intervention: Triple-Endobutton group
Number of subjects: 128
Study 35349415 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase biweekly (responders, n=36)
Number of subjects: 79
Study 35349415 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=43)
Number of subjects: 79
Study 35349415 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase biweekly (responders, n=27 with Fib-4 >1.3)
Number of subjects: 79
Study 35349415 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=27 with Fib-4 >1.3)
Number of subjects: 79
Study 35349415 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum urate area under the curve (AUC)
Number of subjects: 79
Study 35349415 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum urate AUC
Number of subjects: 79
Study 34391270 — intervention group
Group type: EXPERIMENTAL
Intervention: Sling-based manual therapy applied to the cervicothoracic junction (C7-T3) and upper cervical spine (C0-C1).
Number of subjects: 22
Study 34391270 — intervention group
Group type: COMPARATOR
Intervention: Joint mobilization and motor control training for the upper cervical spine (C0-C1) in the control group.
Number of subjects: 22
Study 32830108 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to primary care records in the emergency department
Number of subjects: 8184
Study 32830108 — intervention group
Group type: COMPARATOR
Intervention: Control group (17,449 randomly selected index presentations)
Number of subjects: 8184
Study 35622108 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load volitional failure (LVoF) - 3 sets to failure at 40% one repetition maximum (1RM)
Number of subjects: 27
Study 35622108 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load velocity fatigue (LVeF) - 3 sets to velocity fatigue at 40% 1RM
Number of subjects: 27
Study 35622108 — intervention group
Group type: COMPARATOR
Intervention: High-load (HL) - 3 sets of 8 repetitions at 80% 1RM
Number of subjects: 27
Study 34521374 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated wall liner (ITWL)
Number of subjects: 5666
Study 34521374 — intervention group
Group type: COMPARATOR
Intervention: Indoor residual spraying (IRS)
Number of subjects: 5666
Study 36301617 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study 36301617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34399060 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 137870
Study 34399060 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 137870
Study 34399060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 137870